Trial intelligence / Profile preview

Effect of Preoperative Azithromycin on Peri-implant Bone Remodelling

NCT04280406Phase 1Unknown

Sponsor
Université de Montréal
Start
Feb 2020
Primary completion
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in dental implant failure comparing Azithromycin Group with Placebo Group (2 arms). Primary endpoint: Changes in mesial and distal crestal bone level at 1 year. Status: unknown.

02

Drugs

azithromycin
03

Conditions

dental implant failure

Beyond the preview

Go deeper on NCT04280406.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04280406.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call